Bottom line
What does IHE hold?
IHE held 59 positions as of Jun 30, 2026. Its largest holding is Johnson & Johnson at 22.44% of the fund, and the top 10 positions add up to 79.5%. By asset type it is 100% stocks, 6% cash & short-term funds.
Updated Aug 24, 2026
IHE top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Johnson & Johnson JOHNSON JOHNSON |
Stocks | 22.44% | $255.5M |
| 2 | Eli Lilly And Company ELI LILLY CO |
Stocks | 22.25% | $253.2M |
| 3 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY |
Cash & short-term funds | 6.24% | $71.1M |
| 4 | Merck & Co., Inc. MERCK CO INC |
Stocks | 4.55% | $51.8M |
| 5 | Bristol-myers Squibb Company BRISTOL MYERS SQUIBB CO |
Stocks | 4.37% | $49.7M |
| 6 | Royalty Pharma Plc | Stocks | 4.34% | $49.3M |
| 7 | Viatris Inc. VIATRIS INC |
Stocks | 4.22% | $48.0M |
| 8 | Pfizer Inc. PFIZER INC |
Stocks | 3.96% | $45.1M |
| 9 | Zoetis Inc. ZOETIS INC |
Stocks | 3.73% | $42.4M |
| 10 | Jazz Pharmaceuticals Public Limited Company JAZZ PHARMACEUTICALS PLC |
Stocks | 3.45% | $39.3M |
| 11 | Elanco Animal Health Incorporated ELANCO ANIMAL HEALTH INC |
Stocks | 2.81% | $31.9M |
| 12 | Axsome Therapeutics, Inc. AXSOME THERAPEUTICS INC |
Stocks | 2.42% | $27.5M |
| 13 | Corcept Therapeutics Incorporated CORCEPT THERAPEUTICS INC |
Stocks | 1.90% | $21.6M |
| 14 | Ligand Pharmaceuticals Incorporated LIGAND PHARMACEUTICALS |
Stocks | 1.45% | $16.5M |
| 15 | Definium Therapeutics Inc DEFINIUM THERAPEUTICS INC |
Stocks | 1.39% | $15.8M |
| 16 | Liquidia Corp LIQUIDIA CORP |
Stocks | 1.28% | $14.6M |
| 17 | Indivior Pharmaceuticals, Inc. INDIVIOR PHARMACEUTICALS INC |
Stocks | 1.14% | $13.0M |
| 18 | Crinetics Pharmaceuticals Inc CRINETICS PHARMACEUTICALS INC |
Stocks | 0.90% | $10.3M |
| 19 | Organon & Co. ORGANON CO |
Stocks | 0.81% | $9.2M |
| 20 | Edgewise Therapeutics Inc EDGEWISE THERAPEUTICS INC |
Stocks | 0.70% | $8.0M |
| 21 | Amneal Pharmaceuticals, Inc. AMNEAL PHARMACEUTICALS INC |
Stocks | 0.68% | $7.8M |
| 22 | Enliven Therapeutics Inc ENLIVEN THERAPEUTICS INC |
Stocks | 0.63% | $7.2M |
| 23 | Supernus Pharmaceuticals, Inc. SUPERNUS PHARMACEUTICALS INC |
Stocks | 0.62% | $7.0M |
| 24 | Tarsus Pharmaceuticals Inc TARSUS PHARMACEUTICALS INC |
Stocks | 0.57% | $6.5M |
| 25 | Veradermics Inc VERADERMICS INC |
Stocks | 0.56% | $6.4M |
Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 24, 2026